Willow Biosciences Inc.
WLLW.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 176.70K | 250.20K | 869.80K | 743.10K | 1.48M |
| Total Receivables | 4.90K | 27.10K | 224.30K | 9.50K | 109.30K |
| Inventory | -- | 38.90K | 62.90K | 93.50K | 162.50K |
| Prepaid Expenses | -- | 140.40K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.42M | -- | -- | 399.70K | -- |
| Total Current Assets | 1.60M | 456.60K | 1.16M | 1.25M | 1.75M |
|
|
|||||
| Total Current Assets | 1.60M | 456.60K | 1.16M | 1.25M | 1.75M |
| Net Property, Plant & Equipment | 11.80K | 1.16M | 1.14M | 1.32M | 1.58M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 0.00 | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 109.10K | 48.10K | 48.20K | 48.00K |
| Total Assets | 1.61M | 1.73M | 2.35M | 2.61M | 3.38M |
|
|
|||||
| Total Accounts Payable | 157.90K | 450.40K | 518.20K | 471.30K | 350.80K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 399.70K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.50K | 674.20K | 546.30K | 500.50K | 495.50K |
| Total Finance Division Other Current Liabilities | 1.42M | 260.60K | 382.70K | 407.00K | 386.20K |
| Total Other Current Liabilities | 1.42M | 260.60K | 382.70K | 407.00K | 386.20K |
| Total Current Liabilities | 1.59M | 1.39M | 1.45M | 1.78M | 1.23M |
|
|
|||||
| Total Current Liabilities | 1.59M | 1.39M | 1.45M | 1.78M | 1.23M |
| Long-Term Debt | 503.70K | 496.20K | 521.10K | 507.10K | 505.90K |
| Short-term Debt | -- | -- | -- | 399.70K | -- |
| Capital Leases | -- | 199.50K | 234.70K | 368.20K | 499.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.09M | 2.08M | 2.20M | 2.65M | 2.24M |
|
|
|||||
| Common Stock & APIC | 88.90M | 88.71M | 94.38M | 92.06M | 92.99M |
| Retained Earnings | -89.19M | -88.87M | -93.99M | -91.86M | -91.60M |
| Treasury Stock & Other | -191.30K | -189.00K | -244.30K | -231.60K | -244.40K |
| Total Common Equity | -480.10K | -351.00K | 144.30K | -40.20K | 1.14M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -480.10K | -351.00K | 144.30K | -40.20K | 1.14M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -480.10K | -351.00K | 144.30K | -40.20K | 1.14M |
|
|
|||||